Chitinase 3 like 1 is associated with tumor angiogenesis in cervical cancer.

[1]  N. Tennagels,et al.  Chitinase-3-like protein 1 protects skeletal muscle from TNFα-induced inflammation and insulin resistance. , 2014, The Biochemical journal.

[2]  Y. Modis,et al.  Chitinase 3-like 1 Regulates Cellular and Tissue Responses via IL-13 Receptor α2 , 2013, Cell reports.

[3]  Y. Li,et al.  Targeted blockade of interleukin-8 abrogates its promotion of cervical cancer growth and metastasis , 2012, Molecular and Cellular Biochemistry.

[4]  R. Marthan,et al.  Role of YKL-40 in bronchial smooth muscle remodeling in asthma. , 2012, American journal of respiratory and critical care medicine.

[5]  H. Seno,et al.  Chitinase 3-like 1 promotes macrophage recruitment and angiogenesis in colorectal cancer , 2011, Oncogene.

[6]  Katarzyna M. Wilczynska,et al.  A Complex of Nuclear Factor I-X3 and STAT3 Regulates Astrocyte and Glioma Migration through the Secreted Glycoprotein YKL-40* , 2011, The Journal of Biological Chemistry.

[7]  R. Shao,et al.  A Matrigel-based tube formation assay to assess the vasculogenic activity of tumor cells. , 2011, Journal of visualized experiments : JoVE.

[8]  V. I. Rymar,et al.  Gene Encoding Chitinase 3-Like 1 Protein (CHI3L1) is a Putative Oncogene , 2011, International journal of biomedical science : IJBS.

[9]  M. Mino‐Kenudson,et al.  Chitinase 3-like-1 expression in colonic epithelial cells as a potentially novel marker for colitis-associated neoplasia. , 2011, The American journal of pathology.

[10]  J. Blohmer,et al.  Prognostic significance of angiogenic factors in uterine cervical cancer. , 2011, Anticancer research.

[11]  Jungil Choi,et al.  CHI3L1 (YKL‐40) is expressed in human gliomas and regulates the invasion, growth and survival of glioma cells , 2011, International journal of cancer.

[12]  R. Shao,et al.  Role of YKL-40 in the Angiogenesis, Radioresistance, and Progression of Glioblastoma* , 2011, The Journal of Biological Chemistry.

[13]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[14]  H. Byrne,et al.  Investigation of the influence of high-risk human papillomavirus on the biochemical composition of cervical cancer cells using vibrational spectroscopy. , 2010, The Analyst.

[15]  T. Limpaiboon,et al.  Differential expression of gene profiling in therapeutic response and non-response cervical carcinoma , 2010 .

[16]  R. Shao,et al.  YKL-40, a secreted glycoprotein, promotes tumor angiogenesis , 2009, Oncogene.

[17]  A. Mitsuhashi,et al.  Serum YKL-40 as a marker for cervical adenocarcinoma. , 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

[18]  P. Kiener,et al.  YKL-40 Is Elevated in Patients with Chronic Obstructive Pulmonary Disease and Activates Alveolar Macrophages1 , 2008, The Journal of Immunology.

[19]  D. Hanahan,et al.  Functions of Paracrine PDGF Signaling in the Proangiogenic Tumor Stroma Revealed by Pharmacological Targeting , 2008, PLoS medicine.

[20]  A. Daneri-Navarro,et al.  Protease-activated receptor-2 (PAR-2) in cervical cancer proliferation. , 2008, Gynecologic oncology.

[21]  B. Monk,et al.  Markers of angiogenesis in cervical cancer: A Gynecologic Oncology Group study , 2007 .

[22]  D. Lebensztejn,et al.  Serum level of YKL-40 does not predict advanced liver fibrosis in children with chronic hepatitis B. , 2007, Advances in medical sciences.

[23]  N. Milman,et al.  Increased serum YKL-40 in patients with pulmonary sarcoidosis--a potential marker of disease activity? , 2005, Respiratory medicine.

[24]  P. Kristjansen,et al.  Regulation of YKL‐40 expression during genotoxic or microenvironmental stress in human glioblastoma cells , 2005, Cancer science.

[25]  A. Wiik,et al.  High serum levels of YKL‐40 in patients with systemic sclerosis are associated with pulmonary involvement , 2005, Scandinavian journal of rheumatology.

[26]  I. Christensen,et al.  High serum YKL-40 level in patients with small cell lung cancer is related to early death. , 2004, Lung cancer.

[27]  H. Thaler,et al.  Early detection and prognosis of ovarian cancer using serum YKL-40. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[28]  H. Ling,et al.  The chitinase 3-like protein human cartilage glycoprotein 39 inhibits cellular responses to the inflammatory cytokines interleukin-1 and tumour necrosis factor-alpha. , 2004, The Biochemical journal.

[29]  B. Jensen,et al.  High levels of serum HER-2/neu and YKL-40 independently reflect aggressiveness of metastatic breast cancer. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[30]  L. Punzi,et al.  YKL-40 as a marker of joint involvement in inflammatory bowel disease. , 2003, Clinical chemistry.

[31]  S. Engelholm,et al.  Plasma YKL‐40, as a prognostic tumor marker in recurrent ovarian cancer , 2003, Acta obstetricia et gynecologica Scandinavica.

[32]  H. Nielsen,et al.  High serum YKL‐40 level after surgery for colorectal carcinoma is related to short survival , 2002, Cancer.

[33]  H. Ling,et al.  The chitinase 3-like protein human cartilage glycoprotein 39 (HC-gp39) stimulates proliferation of human connective-tissue cells and activates both extracellular signal-regulated kinase- and protein kinase B-mediated signalling pathways. , 2002, The Biochemical journal.

[34]  A. Hongo,et al.  Vascular endothelial growth factor is implicated in early invasion in cervical cancer. , 1999, European journal of cancer.

[35]  R. Schlegel,et al.  Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. , 1985, The American journal of pathology.